Skip to content

Study · Not a test of the peptide alone · 2006

1 result

Ectopic ACTH syndrome: our experience with 25 cases.

Salgado LR, Fragoso MC, Knoepfelmacher M, Machado MC, Domenice S, Pereira MA, de Mendonça BB

European journal of endocrinology1 Nov 2006Cited by 99 (Europe PMC)

PMID17062889 (opens in a new tab)DOI10.1530/eje.1.02278 (opens in a new tab)PepBankPUB-17062889
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01HumanNot a test of GHRP-6 aloneCase report or seriesActivity measurement

    In patients with ectopic ACTH syndrome, the GHRP‑6 test was positive in two of three cases.

    In plain wordsThe GHRP‑6 diagnostic test was positive in two of three patients with ectopic ACTH syndrome.

    Peptide
    GHRP-6
    Outcome
    Not applicablePositive GHRP-6 diagnostic test
    Study

    n = 3

    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Measurements

    Positive GHRP-6 tests
    2 of 3 cases
    Patients with ectopic ACTH syndrome who had a GHRP-6 test

    Source sentences

    Summary
    GHRP-6 test was positive in two out of three cases.
    2 context sentences
    Summary · context
    Tumor markers, imaging, and outcome data from 25 patients (13F/12M) aged 18-72 years.
    Summary · context
    High dexamethasone suppression test (HDDST), desmopressin test, GHRP-6 test, corticotropin-releasing hormone (CRH) test, IPSS, computed tomography (CT), magnetic resonance imaging (MRI), and (111)In-pentetreotide scintigraphy were revised.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.